Hutchison China MediTech Limited (HCM) Social Stream
HUTCHMED (China) Ltd (HCM) Price Targets From Analysts
Use the tables below to see what analysts covering HUTCHMED (China) Ltd think about its future price and what recommendations they have for investors and traders.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
HCM's average price target has moved down $2.49 over the prior 177 days.
Over the past 177 days, HCM's average upside potential has been 87.1%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
HCM Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
HCM's average broker recommendation rating improved by 0 over the prior 26 weeks.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- HCM has a higher upside potential (average analyst target price relative to current price) than 332.21% of all US stocks.
- HCM has a greater number of analysts covering the stock than 68.3% of all US stocks.
- In terms of how HUTCHMED (China) Ltd fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than 10.01% of that group.
- HCM has a greater average analyst price target than 267.12% of Pharmaceutical Products stocks.
What is the outlook for HCM? Use POWR Ratings for clearer insight into price direction.